Keine Story von F.Hoffman-La Roche Ltd. mehr verpassen.

F.Hoffman-La Roche Ltd.

  • 25.04.2007 – 19:53

    Tarceva(R) Extends Life of Patients with Pancreatic Cancer

    Basel, Switzerland (ots/PRNewswire) - - Newly published results show significant improvement in survival when innovative, oral cancer drug Tarceva is added to chemotherapy New results published by the Journal of Clinical Oncology show that adding Tarceva (erlotinib) to gemcitabine chemotherapy significantly improves survival by 22 percent in patients with advanced pancreatic cancer.(1) This survival ...